Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study

被引:0
|
作者
Chandrasekhar, Jaya [1 ]
Baber, Usman [1 ]
Sartori, Samantha [2 ]
Aquino, Melissa [3 ]
Henry, Timothy D. [4 ]
Kini, Annapoorna [5 ]
Kapadia, Samir [6 ]
Rao, Sunil [7 ]
Weiss, Sandra [8 ]
Muhlestein, Joseph B. [9 ]
Poddar, Kanhaiya L. [6 ]
Baker, Brian A. [10 ]
Keller, Stuart Y. [11 ]
Effron, Mark B. [11 ]
Chao, Jennifer [2 ]
Strauss, Craig E. [12 ]
DeFranco, Anthony [13 ]
Weintraub, William [8 ]
Mehran, Roxana [1 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Mt Sinai Sch Med, New York, NY USA
[3] Icahn Med Mt Sinai, New York, NY USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] Mt Sinai, New York, NY USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] Duke Univ, Med Ctr, Durham, NC USA
[8] Christiana Care Hlth Syst, Newark, DE USA
[9] Intermt Med Ctr, Murray, UT USA
[10] Daiichi Sankyo, Parsippany, NJ USA
[11] Eli Lilly & Co, Indianapolis, IN 46285 USA
[12] Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA
[13] Aurora Cardiovasc Serv, Milwaukee, WI USA
关键词
Acute coronary syndromes; Angioplasty; Antiplatelet therapy;
D O I
10.1016/j.jacc.2015.08.234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-219
引用
收藏
页码:B84 / B85
页数:2
相关论文
共 50 条
  • [21] Effects Of High Versus Standard Dose Clopidogrel and High Versus Low Dose Aspirin In Over 16,000 Patients Undergoing PCI for ACS or STEMI: Results of the CURRENT-PCI Study
    Mehta, Shamir R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : XVI - XVII
  • [22] Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel
    Doll, Jacob A.
    Neely, Megan L.
    Roe, Matthew T.
    Armstrong, Paul W.
    White, Harvey D.
    Prabhakaran, Dorairaj
    Winters, Kenneth J.
    Duvvuru, Suman
    Sundseth, Scott S.
    Jakubowski, Joseph A.
    Gurbel, Paul A.
    Bhatt, Deepak L.
    Ohman, E. Magnus
    Fox, Keith A. A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (08) : 936 - 947
  • [23] IMPACT OF CLOPIDOGREL ON PATIENTS WITH ACS UNDERGOING CORONARY BYPASS SURGERY: THE PRACTICE STUDY
    Lamy, A.
    Noiseux, N.
    Kieser, T.
    Fremes, S.
    Novick, R. J.
    Cartier, R.
    Cheung, A.
    Bernstein, V.
    Yau, T. M.
    Ou, Y.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 144D - 144D
  • [24] IMPACT OF CLOPIDOGREL ON PATIENTS WITH ACS UNDERGOING CORONARY BYPASS SURGERY: THE PRACTICE STUDY
    Lamy, A.
    Noiseux, N.
    Kieser, T.
    Fremes, S.
    Bernstein, V.
    Brown, C. D.
    Novick, R. J.
    Cartier, R.
    Cheung, A.
    Yau, T. M.
    Ou, Y.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S254 - S254
  • [25] Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention A Report From the PROMETHEUS Study
    Baber, Usman
    Chandrasekhar, Jaya
    Sartori, Samantha
    Aquino, Melissa
    Kini, Annapoorna S.
    Kapadia, Samir
    Weintraub, William
    Muhlestein, Joseph B.
    Vogel, Birgit
    Faggioni, Michela
    Farhan, Serdar
    Weiss, Sandra
    Strauss, Craig
    Toma, Catalin
    DeFranco, Anthony
    Baker, Brian A.
    Keller, Stuart
    Effron, Mark B.
    Henry, Timothy D.
    Rao, Sunil
    Pocock, Stuart
    Dangas, George
    Mehran, Roxana
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (20) : 2017 - 2025
  • [26] Comparative Efficacy and Safety of Prasugrel and Clopidogrel in Patients With STEMI Undergoing Primary PCI in the Prasugrel Core Population in Clinical Practice. Results of the Prospective ALKK-registry
    Zeymer, Uwe
    Hochadel, Matthias
    Gitt, Anselm
    Zahn, Ralf
    CIRCULATION, 2014, 130
  • [27] Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction Results of the ISAR-SHOCK registry
    Orban, Martin
    Mayer, Katharina
    Morath, Tanja
    Bernlochner, Isabell
    Hadamitzky, Martin
    Braun, Siegmund
    Schulz, Stefanie
    Hoppmann, Petra
    Hausleiter, Joerg
    Tiroch, Klaus
    Mehilli, Julinda
    Schunkert, Heribert
    Massberg, Steffen
    Laugwitz, Karl-Ludwig
    Sibbing, Dirk
    Kastrati, Adnan
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (06) : 1190 - 1197
  • [28] TRIPLE THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: A COMPARISON OF CLOPIDOGREL VERSUS PRASUGREL FROM THE TRANSLATE-ACS STUDY
    Jackson, Larry R.
    Zettler, Marjorie
    Peterson, Eric
    Ju, Christine
    Effron, Mark
    Messenger, John
    Cohen, David
    Stone, Gregg
    Wang, Tracy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A26 - A26
  • [29] Comparative efficacy and safety of prasugrel and clopidogrel in patients with STEMI undergoing primary PCI in the prasugrel core population in clinical practice. Results of the prospective ALKK-Regist
    Riedmaier, P.
    Hochadel, M.
    Zahn, R.
    Schuhmacher, S.
    Kerber, S.
    Elsaesserr, A.
    Schuehlen, H.
    Zeymer, U.
    EUROPEAN HEART JOURNAL, 2015, 36 : 230 - 230
  • [30] Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI
    Angiolillo, Dominick J.
    Franchi, Francesco
    Waksman, Ron
    Sweeny, Joseph M.
    Raveendran, Ganesh
    Teng, Renli
    Zhao, Yonggang
    Carlson, Glenn
    Khan, Naeem
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (06) : 603 - 613